ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

カルベニシリン

Carbenicillin

HCID 20824
反応を作成
印刷

データを補完しています。しばらくしてからページを更新すると最新の内容を表示できます

基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
4697-36-3
標準SMILES
CC1(C)S[C@@H]2[C@H](NC(=O)C(C(=O)O)c3ccccc3)C(=O)N2[C@H]1C(=O)O
InChIKey
FPPNZSSZRUTDAP-UWFZAAFLSA-N
分子式
C17H18N2O6S
平均分子量
378.4 g/mol
単同位体質量
378.08855747

概要

Carbenicillin is a penicillin antibiotic having a 6beta-2-carboxy-2-phenylacetamido side-chain. It has a role as an antibacterial drug. It is a penicillin and a penicillin allergen. It is a conjugate acid of a carbenicillin(2-).

名称と識別子

優先名称
Carbenicillin
IUPAC
(2S,5R,6R)-6-[(2-carboxy-2-phenylacetyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
現地名
カルベニシリン
英語名
CARBENICILLIN
分子式
C17H18N2O6S
分子量
378.4

名称と別名

carbenicillin4697-36-3CarboxybenzylpenicillinCarbenicilinaCarbenicillinealpha-CarboxybenzylpencillinCarbenicillinumCarbenicillinaCBPCalpha-Phenyl(carboxymethylpenicillin)6-(alpha-Carboxyphenylacetamido)penicillanic acidCHEBI:3393
名称をさらに表示
N-[(2S,5R,6R)-2-カルボキシ-3,3-ジメチル-7-オキソ-4-チア-1-アザビシクロ[3.2.0]ヘプタン-6-イル]-2-フェニルマロンアミド酸CBPC【カルベニシリン】カルベニシリン(2S,5R,6R)-6-(2-カルボキシ-2-フェニルアセトアミド)-3,3-ジメチル-7-オキソ-4-チア-1-アザビシクロ[3.2.0]ヘプタン-2-カルボン酸Pyocianilonamic acidARBENICILLINCARBENICILLIN USP/EP/BPLactic Acid Impurity 53CARBENICILLIN READY MADECarbenicillinum natricum(α-Carboxybenzyl)penicillin
G42ZU72N5G(2S,5R,6R)-6-[(2-carboxy-2-phenylacetyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid(2S,5R,6R)-6-(2-carboxy-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acidN-(2-Carboxy-3,3-dimethyl-7-oxo-4-thia-azabicyclo(3.2.0)hept-6-yl)-2-phenylmalonamic acidDTXSID6048464Malonamic acid, N-(2-carboxy-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)hept-6-yl)-2-phenyl-N-(2-carboxy-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)hept-6-yl)-2-phenylmalonamic acid4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-((carboxyphenylacetyl)amino)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta))-

物性

構造計算による物性補完中

XLogP
1.1
極性表面積
149 Ų
水素結合供与体数
3
水素結合受容体数
7
回転可能結合数
5
重原子数
26
形式電荷
0
複雑度
645

実験および物理化学的性質

DrugsPharmaceuticals -> Antibiotics
pHPH: (1% SOLN, WT/VOL) BETWEEN 6.8 & 7.5
LogP · 2 件

logP = 1.13

1.8

Solubility · 2 件

WHITE TO OFF-WHITE, CRYSTALLINE POWDER; BITTER TASTE; HYGROSCOPIC; ODORLESS; PKA1: 2.76; PKA2: 3.5; SPECIFIC OPTICAL ROTATION: +175 TO +185 DEG; 1 G SOL IN 1.2 ML WATER, 25 ML ALCOHOL; SOL IN METHANOL, DIL ALKALI, DIL ACID; INSOL IN ACETONE, CHLOROFORM, ETHER /DISODIUM/

3.90e-01 g/L

Human DrugsBreast Feeding; Lactation; Milk, Human; Anti-Infective Agents; Antibacterial Agents; Penicillins
Animal DrugsPharmaceuticals -> Animal Drugs -> Approved in Taiwan
Physical DescriptionSolid
Stability/Shelf Life · 2 件

UNSTABLE IN ACID /DISODIUM/

Extended-spectrum penicillins are generally stable for several yr in the dry state @ room temp; however, the drugs are stable only for short periods of time in soln unless frozen. Like other penicillins, stability of extended-spectrum penicillins is pH and temp dependent ... carbenicillin indanyl sodium is more resistant to acid-catalyzed hydrolysis than carbenicillin and is generally stable in the presence of acidic gastric secretions following oral admin.

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 4 件

Danger

H317 (100%): May cause an allergic skin reaction [Warning Sensitization, Skin]

P233, P260, P261, P271, P272, P280, P284, P302+P352, P304+P340, P321, P333+P317, P342+P316, P362+P364, P403, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 39 reports by companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

危険有害性情報

Regulatory InformationREACH registered substance: CBPC (EC: 434-340-1)
Other Safety InformationIMAP assessments - 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[(carboxyphenylacetyl)amino]-3,3-dimethyl-7-oxo-, [2S-(2.alpha.,5.alpha.,6.beta.)]-: Environment tier I assessment
FDA Requirements · 1 件

Manufacturers, packers, and distributors of drug and drug products for human use are responsible for complying with the labeling, certification, and usage requirements as prescribed by the Federal Food, Drug, and Cosmetic Act, as amended (secs 201-902, 52 Stat. 1040 et seq., as amended; 21 U.S.C. 321-392).

Hazard Classes and CategoriesSkin Sens. 1 (100%)

安全と保護具

Storage ConditionsCarbenicillin indanyl sodium tablets should be protected from moisture and stored in tight containers at a temperature not exceeding 30 °C. /Carbenicillin indanyl sodium/
Disposal Methods · 1 件

SRP: At the time of review, criteria for land treatment or burial (sanitary landfill) disposal practices are subject to significant revision. Prior to implementing land disposal of waste residue (including waste sludge), consult with environmental regulatory agencies for guidance on acceptable disposal practices.

化学と産業

薬理情報

ATC Code · 2 件

J - Antiinfectives for systemic use

QJ - Antiinfectives for systemic use

Protein Binding30 to 60%
Pharmacodynamics · 1 件

Carbenicillin is a semisynthetic penicillin. Though carbenicillin provides substantial <i>in vitro</i> activity against a variety of both gram-positive and gram-negative microorganisms, the most important aspect of its profile is in its antipseudomonal and antiproteal activity. Because of the high urine levels obtained following administration, carbenicillin has demonstrated clinical efficacy in urinary infections due to susceptible strains of: <i>Escherichia coli</i>, <i>Proteus mirabilis</i>, <i>Proteus vulgaris</i>, <i>Morganella morganii</i>, <i>Pseudomonas</i> species, <i>Providencia rettgeri</i>, <i>Enterobacter</i> species, and <i>Enterococci</i> (<i>S. faecalis</i>).

Mechanism of Action · 3 件

Free carbenicillin is the predominant pharmacologically active fraction of the salt. Carbenicillin exerts its antibacterial activity by interference with final cell wall synthesis of susceptible bacteria. Penicillins acylate the penicillin-sensitive transpeptidase C-terminal domain by opening the lactam ring. This inactivation of the enzyme prevents the formation of a cross-link of two linear peptidoglycan strands, inhibiting the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that carbenicillin interferes with an autolysin inhibitor.

The penicillins and their metabolites are potent immunogens because of their ability to combine with proteins and act as haptens for acute antibody-mediated reactions. The most frequent (about 95 percent) or "major" determinant of penicillin allergy is the penicilloyl determinant produced by opening the beta-lactam ring of the penicillin. This allows linkage of the penicillin to protein at the amide group. "Minor" determinants (less frequent) are the other metabolites formed, including native penicillin and penicilloic acids. /Penicillins/

Bactericidal; inhibit bacterial cell wall synthesis. Action is dependent on the ability of penicillins to reach and bind penicillin-binding proteins (PBPs) located on the inner membrane of the bacterial cell wall. Penicillin-binding proteins (which include transpeptidases, carboxypeptidases, and endopeptidases) are enzymes that are involved in the terminal stages of assembling the bacterial cell wall and in reshaping the cell wall during growth and division. Penicillins bind to, and inactivate, penicillin-binding proteins, resulting in the weakening of the bacterial cell wall and lysis. /Penicillins/

関連反応

7 件
反応記録を作成
HRID 519254 の反応式
HRID 519254反応物として
HRID 644586 の反応式
HRID 644586反応物として
HRID 713537 の反応式
HRID 713537反応物として
HRID 1833409 の反応式
HRID 1833409生成物として
HRID 1879592 の反応式
HRID 1879592反応物として
HRID 2195620 の反応式
HRID 2195620反応物として
HRID 2215888 の反応式
HRID 2215888反応物として

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート

データベース識別子

CAS
4697-36-3
PubChem CID
20824
DTXSID
DTXSID6048464
ChEMBL
CHEMBL1214
ChEBI
CHEBI:3393
UNII
G42ZU72N5G
EC Number
225-171-0、434-340-1
Nikkaji
J3.066J

物理化学的性質

沸点
737.8 · 737.8±60.0 °C(Predicted)
比重(密度)
1.53 · 1.53±0.1 g/cm3(Predicted)
貯蔵温度
20 °C · −20°C
溶解性
Soluble in DMSO
外見
Powder
酸解離定数(Pka)
2.22 · pKa 2.22±0.05(H2O t = 25.0 I = 0.15 (KCl)) (Uncertain);3.25±0.02 (Uncertain)
水溶解度
2 O: · H2O: 100mg/mLethanol: 100mg/mL
InChIKey
FPPNZSSZRUTDAP-UWFZAAFLSA-N
SMILES
CC1(C)S[C@@H]2[C@H](NC(=O)C(C(O)=O)c3ccccc3)C(=O)N2[C@H]1C(O)=O
CAS データベース
4697 · 4697-36-3

毒性情報

Interactions · 5 件

Extended-spectrum penicillins are physically and/or chemically incompatible with aminoglycosides and can inactivate the drugs in vitro. The extent of in vitro inactivation of aminoglycosides by penicillins depends on the specific drugs involved and appears to be directly proportional to the penicillin concn, length of exposure, and temp ... Most in vitro studies indicate that carbenicillin ... inactivates aminoglycosides at a faster rate than mazlocillin, piperacillin, or ticarcillin.

Extended-spectrum penicillins can also inactivate aminoglycosides in vivo. In patients with impaired renal function, concomitant admin of carbenicillin ... and gentamicin has resulted in decreased serum aminoglycoside concn and serum half-lives compared with admin of the aminoglycoside alone.

Some in vitro studies indicate that the antibacterial activity of extended-spectrum penicillins may be additive or partially synergistic with other beta-lactam antibiotics ... . /Extended-spectrum penicillins/

In vitro studies indicate that the combination of carbenicillin ... with clavulanic acid, a beta-lactamase inhibitor, results in a synergistic bactericidal effect against many strains of beta-lactamase-producing bacteria.

For more Interactions (Complete) data for CARBENICILLIN (7 total), please visit the HSDB record page.

Human Toxicity Excerpts · 5 件

MASSIVE IV DOSES IN MAN...MAY RESULT IN AN ENCEPHALOPATHY WITH MUSCULAR HYPERIRRITABILITY, MYOCLONUS, VISUAL & AUDITORY HALLUCINATIONS & GENERALIZED CONVULSIONS. ... ALLERGIC REACTIONS ARE FAR MORE COMMON THAN FRANK TOXICITY. ANAPHYLACTIC SHOCK IS RARE, BUT CAN FOLLOW ONE-MICROGRAM TEST DOSE. /PENICILLINS/

SKIN RASHES OF ALL TYPES HAVE BEEN OBSERVED WHEN PENICILLIN SENSITIZATION HAS OCCURRED. ...VESICULAR, & BULLOUS ERUPTIONS MAY DEVELOP. PURPURIC LESIONS ARE UNCOMMON & ARE USUALLY RESULT OF VASCULITIS; THROMBOPENIC PURPURA MAY OCCUR VERY RARELY. HENOCH-SCHOENLEIN PURPURA WITH RENAL INVOLVEMENT HAS BEEN RARE... /PENICILLINS/

CONTACT DERMATITIS IS OBSERVED...IN PHARMACISTS, NURSES, & PHYSICIANS WHO PREPARE PENICILLIN SOLN... MORE SEVERE REACTIONS INVOLVING SKIN ARE EXFOLIATIVE DERMATITIS & EXUDATIVE ERYTHEMA MULTIFORME OF EITHER ERYTHEMATOPAPULAR OR VESICULOBULLOUS TYPE...CONSTITUTE CHARACTERISTIC STEVENS-JOHNSON SYNDROME. /PENICILLINS/

VARIETY OF ORAL LESIONS HAVE RESULTED FROM SENSITIZATION TO PENICILLIN. AMONG THESE ARE ACUTE GLOSSITIS, SEVERE STOMATITIS WITH LOSS OF BUCCAL MUCOUS MEMBRANES, FURRED TONGUE, BLACK OR BROWN TONGUE, & CHEILOSIS. /PENICILLINS/

For more Human Toxicity Excerpts (Complete) data for CARBENICILLIN (48 total), please visit the HSDB record page.

Drug Induced Liver Injury · 5 件

Drug-Induced Liver Injury Severity and Toxicity (DILIst)

carbenicillin

DILI Positive

Oral

DOI:10.1016/j.drudis.2019.09.022

Non-Human Toxicity Excerpts · 5 件

DEATH FROM RESP FAILURE WITH OR WITHOUT CONVULSIONS OCCURRED 6-18 HR AFTER SINGLE ORAL DOSES /TO MICE, RATS, RABBITS/. ACUTE GASTROENTERITIS & CARDIOVASCULAR SHOCK... /PENICILLINS/

IN HAMSTERS DRUG IS SOMEWHAT MORE TOXIC BY ORAL THAN BY SC ROUTE WHEN OBSERVED FOR 14 DAYS AFTER SINGLE DOSES. ... PERHAPS SENSITIVITY OF GUINEA PIGS IS RELATED TO EFFECTS ON INTESTINAL MICROFLORA. /PENICILLINS/

...ENCEPHALOPATHY WITH MUSCULAR HYPERIRRITABILITY, MYOCLONUS, VISUAL & AUDITORY HALLUCINATIONS & GENERALIZED CONVULSIONS. ...ELICITED IN RATS & CATS WITH DOSES TO 3-4 MILLION UNITS/KG... /PENICILLINS/

IT HAD FEW SIDE EFFECTS WHEN GIVEN REPEATEDLY TO MICE, RATS, & CATS. IV LD50 VALUE FOR MICE WAS 47 MG/20 G. SC ADMIN OF 250 OR 1000 MG/KG TO RATS HAD NO SIDE EFFECTS. IN CATS, 300-500 MG/KG DECR ARTERIAL PRESSURE.

DEATH FROM RESP FAILURE WITH OR WITHOUT CONVULSIONS OCCURRED 6-18 HR AFTER SINGLE ORAL DOSES /TO CATS & DOGS/. ACUTE GASTROENTERITIS & CARDIOVASCULAR SHOCK...ALSO TRUE FOR GUINEA PIGS EXCEPT THAT A LATE...& GRADUALLY DEVELOPING TOXEMIA KILLED ALL SURVIVORS OF ACUTE RESPONSE. /PENICILLINS/

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation

法規制情報

FDA Requirements · 1 件

Manufacturers, packers, and distributors of drug and drug products for human use are responsible for complying with the labeling, certification, and usage requirements as prescribed by the Federal Food, Drug, and Cosmetic Act, as amended (secs 201-902, 52 Stat. 1040 et seq., as amended; 21 U.S.C. 321-392).

安全データ

wgk
2
ridadr
UN 1170 3/PG 3
risk_code
10-42/43
hazard_code
Xn
safety_code
36/37-45-22
Hazard Classifications
Flam. Liq. 3Resp. Sens. 1Skin Sens. 1
ストレージクラス
3 - Flammable liquids
有毒物質データの
4697-36-3(Hazardous Substances Data)
Biological Half-Life · 2 件

1 hour

...T 1/2...IN INDIVIDUALS WITH NORMAL RENAL FUNCTION IS ABOUT 1 HR...PROLONGED TO ABOUT 2 HR IN PRESENCE OF HEPATIC DYSFUNCTION.

Metabolism/MetabolitesMinimal.
FDA Pharmacological Classification · 5 件

G42ZU72N5G

CARBENICILLIN

Established Pharmacologic Class [EPC] - Penicillin-class Antibacterial

Chemical Structure [CS] - Penicillins

Carbenicillin is a Penicillin-class Antibacterial.

MeSH Pharmacological ClassificationSubstances that inhibit the growth or reproduction of BACTERIA.
Absorption, Distribution and Excretion · 6 件

Rapidly absorbed from the small intestine following oral administration. Oral bioavailability is 30 to 40%.

CARBENICILLIN IS NOT ABSORBED FROM GI TRACT &, THEREFORE MUST BE GIVEN PARENTERALLY. ... IM INJECTION OF 1 G PRODUCES PEAK PLASMA CONCN OF 15-20 UG/ML IN 1/2-2 HR... MAX PLASMA CONCN ARE ABOUT 4 TIMES HIGHER AFTER IV THAN AFTER IM ADMIN... IV INFUSION...1 G/HR RESULTS IN AVG PLASMA CONCN OF APPROX 150 UG/ML.

ABOUT 50% OF ANTIBIOTIC IN PLASMA IS PROTEIN BOUND. ...CARBENICILLIN IS EXCRETED PRIMARILY BY RENAL TUBULES. ABOUT 75-80%...IS RECOVERABLE IN ACTIVE FORM IN URINE IN 9 HR.

Carbenicillin is not stable in acids nor does it resist penicillinases; thus it is administered parenterally because of poor absorption following oral administration. A parenteral dose of 50-200 mg/kg is divided for administration every 4-6 hr.

Although carbenicillin is eliminated from the bovine mammary gland within 72 hr posttreatment, mastitis produced by P. aeruginosa is not effectively treated; resistant organisms are recovered 24-48 hr postinfusion.

For more Absorption, Distribution and Excretion (Complete) data for CARBENICILLIN (11 total), please visit the HSDB record page.

Cellular LocationsMembrane

用途と製造

UsesMEDICATION
U.S. Imports · 2 件

(1976) 1.4X10+5 G-PRINCPL CUSTMS DIST-DISODIUM

(1979) 4.7X10+6 G-PRINCPL CUSTMS DIST-DISODIUM

U.S. Production · 2 件

(1977) PROBABLY MORE THAN 9.07X10+5 G-DISODIUM

(1979) PROBABLY MORE THAN 9.07X10+5 G-DISODIUM

Consumption PatternsESSENTIALLY 100% AS AN ANTIBIOTIC (AS DISODIUM SALT)
Methods of ManufacturingACYLATION OF 6-AMINOPENICILLANIC ACID WITH MONOESTERS OF PHENYLMALONIC ACID FOLLOWED BY SAPONIFICATION WITH THE AID OF ALPHA-CHYMOTRYPSIN OR PANCREATIN
Formulations/PreparationsBRL-2064, CARBENICILLIN DISODIUM, CP-15-639-2, ANABACTYL, CARBAPEN, CARBECIN, GEOPEN, HYOPER, MICROCILLIN, PYOCIANIL, PYOPEN /DISODIUM/
Use ClassificationPharmaceuticals -> Animal Drugs -> Approved in Taiwan
General Manufacturing Information · 2 件

THIS DRUG IS PENICILLINASE-SUSCEPTIBLE DERIVATIVE OF 6-AMINOPENICILLANIC ACID.

PREPN OF DISODIUM SALT: BELG PATENT 646,991, CORRRESPONDING TO BRAIN, NAYLER, US PATENT 3,282,926 (1964 & 1966 TO BEECHAM).

応用分野 · 2 件

解説カルベニシリン,アンピシリン,ヘタシリン,シクラシリン,スルベニシリン,ピバンピシリンなどとともに広域性ペニシリン系抗生物質である。他のペニシリン類に比して広い抗菌スペクトルをもち,グラム陰性桿菌にも有効である。アンピシリンに耐性を示す緑膿菌に有効であり,大量投与が可能なので,緑膿菌感染症に用いうる数少い抗生物質の一つである。酸に耐性がないため,非経口的に投与される。一般のペニシリンと同様,毒性は低い。副作用の大部分はアレルギー性反応によるもので,すべてのペニシリン類は交差感受性を示す。使用に際して皮内テストが不可欠である。

使用Antibacterial.

上流・下流製品情報

上流原料

6-アミノペニシラン酸水素フェニルマロン酸塩化スルフィニルベンジルアルコール炭酸水素ナトリウム

補足説明

定義ChEBI: A penicillin antibiotic having a 6beta-2-carboxy-2-phenylacetamido side-chain.